These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16157)

  • 1. [Use of coronaroactive agents with beta-stimulating effect in ischemic heart disease].
    Kukes VG; Buianov VV; Semenov VN; Abugov AM; Borovkov AI
    Kardiologiia; 1976 Apr; 16(4):88-93. PubMed ID: 16157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of beta-blocking agents and beta stimulators on the intracardiac hemodynamics and myocardial contraction in ischemic heart disease].
    At'kov OIu; Krol VA; Chumburidze VB
    Ter Arkh; 1977; 49(10):57-60. PubMed ID: 22937
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of ildamen on the heart conduction system in ischemic heart disease patients].
    Shilov AM; Borisov VG
    Farmakol Toksikol; 1987; 50(5):34-6. PubMed ID: 2891566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glycoside and coronary therapy with Ildamen-Novodigal].
    Moosdorf S; Reincke J
    Ther Ggw; 1974 Nov; 113(11):1921-39. PubMed ID: 4462219
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of antianginal agents with a beta-adrenostimulating component of their action on the ischemic myocardium].
    Kaverina NV; Chichkanov GG; Bogolepov AK; Azvolinskaia TN; Matsievskiĭ DD
    Farmakol Toksikol; 1982; 45(4):37-41. PubMed ID: 6127232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies of L- as well as DL-oxyfedrine in healthy people and patients with chronic ischemic heart diseases].
    Teichmann W; Lukesch KH; Rikirsch P; Schäbitz J; Schmidt GA; Vogel HC; Sziegoleit W; Enke H
    Z Arztl Fortbild (Jena); 1976 May; 70(10):554-9. PubMed ID: 782052
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of Ildamen].
    Krzemińska-Pakuła M; Musiał WJ
    Pol Tyg Lek; 1979 Dec; 34(52):2053-5. PubMed ID: 396524
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of drugs on myocardial perfusion scanning and wall motion in patients with coronary insufficiency.
    Simon H; Felix R; Hedde J
    Acta Med Scand Suppl; 1978; 615():85-91. PubMed ID: 358767
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immediate action of oxyphedrin as evaluated using the exertion test in coronary patients].
    Velasco Rami JA; Tormo Alfonso V; Roda Nicolas J; Serra Sister E
    Rev Esp Cardiol; 1977; 30(1):17-21. PubMed ID: 854620
    [No Abstract]   [Full Text] [Related]  

  • 10. Echocardiographic evaluation of acute administration of oxyfedrine in patients with coronary artery disease.
    Maione S; Teti G; Vigorito C; Perticone F; Serino C; Giunta A; Condorelli M
    Curr Med Res Opin; 1981; 7(4):241-6. PubMed ID: 7226873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of the effect of anti-angina drugs with adrenergic beta receptor agonist action on the collateral hemodynamics and redistribution of the blood flow in chronic myocardial ischemia].
    Chichkanov GG; Bogolepov AK; Matsievskiĭ DD
    Kardiologiia; 1981 Oct; 21(10):85-8. PubMed ID: 6117671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term therapy of angina pectoris. Evaluation of the effectiveness and tolerance of oxyfedrine in ambulatory patients].
    Schieffer H; Sternitzke N
    Fortschr Med; 1984 May; 102(19):551-6. PubMed ID: 6429021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Various aspects of drug therapy of chronic forms of ischemic heart disease].
    Kipshidze NN; Chumburidze VB
    Kardiologiia; 1985 Sep; 25(9):37-40. PubMed ID: 2867241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of oxyfedrine in the treatment of coronary disease. Apropos of 100 cases].
    Hiltenbrandt C; Gerard A; Maecker P; Desruelles J
    Lille Med; 1972 Oct; 17(9):1288-93. PubMed ID: 4657642
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of the partial beta-adrenergic receptor agonist, oxyfedrine, on regional myocardial blood flow and left ventricular function in patients with coronary artery disease].
    Dirschinger J; Fleck E; Rudolph W
    Herz; 1982 Dec; 7(6):351-7. PubMed ID: 7160821
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of the effect of ildamen and nonachlazin on the blood supply and activities of the heart].
    Kaverina NV; Chichkanov GG; Chumburidze VB
    Kardiologiia; 1978 Mar; 18(3):88-93. PubMed ID: 642245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxyfedrine.
    Lancet; 1981 Jan; 1(8210):25-6. PubMed ID: 6109057
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of oxyfedrine on myocardial infarct size following coronary artery occlusion in rats (author's transl)].
    Chiariello M; Brevetti G; Petillo F; Ferro G; Giasi M; Condorelli M
    G Ital Cardiol; 1981; 11(3):373-9. PubMed ID: 6116640
    [No Abstract]   [Full Text] [Related]  

  • 19. [Positive inotropic effect of coronary-active drug: oxyfedrine].
    Conti G; Moreschini G; Pelosi M
    Minerva Cardioangiol; 1980 Sep; 28(9):645-7. PubMed ID: 7465070
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxyfedrine and cardiac inotropism in coronary artery disease.
    Krishnaswami S; Sathyamurthy I; Mao R; Padmakumar P
    Indian Heart J; 1984; 36(3):161-5. PubMed ID: 6490047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.